Eagle Bay Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50
| Closed | -$392 | – | 967 |
|
|
2024
Q4 | $392 | Hold |
50
| – | – | ﹤0.01% | 971 |
|
|
2024
Q3 | $658 | Hold |
50
| – | – | ﹤0.01% | 1306 |
|
|
2024
Q2 | $604 | Hold |
50
| – | – | ﹤0.01% | 955 |
|
|
2024
Q1 | $813 | Hold |
50
| – | – | ﹤0.01% | 932 |
|
|
2023
Q4 | $341 | Hold |
50
| – | – | ﹤0.01% | 803 |
|
|
2023
Q3 | $273 | Hold |
50
| – | – | ﹤0.01% | 827 |
|
|
2023
Q2 | $340 | Hold |
50
| – | – | ﹤0.01% | 817 |
|
|
2023
Q1 | $251 | Hold |
50
| – | – | ﹤0.01% | 889 |
|
|
2022
Q4 | $244 | Hold |
50
| – | – | ﹤0.01% | 890 |
|
|
2022
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 880 |
|
|
2022
Q2 | $757 | Buy |
+50
| New | +$757 | ﹤0.01% | 884 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$1K | – | 981 |
|
|
2021
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 1033 |
|
|
2021
Q3 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 1009 |
|